Get started
Author

Janna-Lisa Velthaus

Observed names: J. Velthaus, Janna-Lisa Velthaus (Hamburg)
OpenAlex ID: A5045732772
Determination of PD-L1 Expression in Circulating Tumor Cells of NSCLC Patients and Correlation with Response to PD-1/PD-L1 Inhibitors
2019 · Melanie Janning, Franca Kobus, et al. · Cancers · 143
PDF
Mast cells decrease efficacy of anti-angiogenic therapy by secreting matrix-degrading granzyme B
2017 · M. Wroblewski, R. Bauer, et al. · Nature Communications · 79
PDF
Efficacy of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in NSCLC Harboring ERBB2 Mutations
2021 · Felix C. Saalfeld, Carina Wenzel, et al. · Journal of Thoracic Oncology · 67
PDF
Identifying the Steps Required to Effectively Implement Next-Generation Sequencing in Oncology at a National Level in Europe
2022 · Denis Horgan, Giuseppe Curigliano, et al. · Journal of Personalized Medicine · 62
PDF
Frequency of Circulating Tumor Cells (CTC) in Patients with Brain Metastases: Implications as a Risk Assessment Marker in Oligo-Metastatic Disease
2018 · Annkathrin Hanssen, Carlotta Riebensahm, et al. · Cancers · 54
PDF
Outcome of First-Line Treatment With Pembrolizumab According to KRAS/TP53 Mutational Status for Nonsquamous Programmed Death-Ligand 1–High (≥50%) NSCLC in the German National Network Genomic Medicine Lung Cancer
2023 · Philip Bischoff, Martin Reck, et al. · Journal of Thoracic Oncology · 52
PDF
Conceptual framework for precision cancer medicine in Germany: Consensus statement of the Deutsche Krebshilfe working group ‘Molecular Diagnostics and Therapy’
2020 · C. Benedikt Westphalen, Carsten Bokemeyer, et al. · European Journal of Cancer · 30
Identification of a High-Level MET Amplification in CTCs and cfTNA of an ALK-Positive NSCLC Patient Developing Evasive Resistance to Crizotinib
2018 · Lars-Arne Berger, Melanie Janning, et al. · Journal of Thoracic Oncology · 23
PDF
Trametinib in combination with hydroxychloroquine or palbociclib in advanced metastatic pancreatic cancer: data from a retrospective, multicentric cohort (AIO AIO-TF/PAK-0123)
2024 · David Witte, Ina Pretzell, et al. · Journal of Cancer Research and Clinical Oncology · 13
PDF
Lorlatinib Induces Durable Disease Stabilization in a Pancreatic Cancer Patient with a ROS1 p.L1950F Mutation: Case Report
2021 · Janna-Lisa Velthaus, Peter Iglauer, et al. · Oncology Research and Treatment · 7
Use of Process Modelling for Optimization of Molecular Tumor Boards
2022 · Katharina Lauk, Mia-Carlotta Peters, et al. · Applied Sciences · 4
PDF
Acceptance and Benefits of Two Different Strategies to Timely Integrate Specialist Palliative Care into Routine Cancer Care: A Randomized Pilot Study
2021 · Anneke Ullrich, Svenja Wilde, et al. · Oncology Research and Treatment · 3
Last Resort? Rationale for Comprehensive Molecular Analysis in Treatment-Refractory R/M HNSCC: A Case Report of Remarkable Response to Sacituzumab Govitecan Following Molecular and Functional Characterization
2025 · Henrike Barbara Zech, Philippe Schafhausen, et al. · Biomedicines · 2
PDF
Recurrence patterns and impact of brain metastases in synchronous single organ oligometastatic lung cancer following local ablative treatment – A multicenter analysis
2022 · Nikolaj Frost, Julia Roeper, et al. · Lung Cancer · 2
Effect of mast cells on efficacy of anti-angiogenic therapy by secreting matrix-degrading granzyme b.
2017 · Mark Wroblewski, Janna-Lisa Velthaus, et al. · Journal of Clinical Oncology · 1
Molekulare Tumorboards: Bestandsaufnahme und Perspektiven
2023 · Alexej Ballhausen, Janna-Lisa Velthaus · InFo Hämatologie + Onkologie
Corrigendum to “Conceptual framework for precision cancer medicine in Germany: Consensus statement of the Deutsche Krebshilfe working group ‘Molecular Diagnostics and Therapy’” [European Journal of Cancer 135 (2020) 1-7]
2021 · C. Benedikt Westphalen, Carsten Bokemeyer, et al. · European Journal of Cancer
Aufbau von Strukturen zur Patientenversorgung
2018 · Janna-Lisa Velthaus, Carsten Bokemeyer, et al. · Info Onkologie
Maligne periphere Nervenscheidentumoren bei Neurofibromatose Typ 1: Angiogeneseprofil
2016 · Janna-Lisa Velthaus
Works count: 19
Citation count: 542
H-index: 9
I10-index: 9
Year
Topic
Type